Breakthrough therapies do not fail because the science stops working. They fail when healthcare is not designed for the ...
ZPB Associates as appointed Rachel Allan as Managing Director. Allan joined the agency as a Senior Account Manager in 2016, ...
In the latest episode of Hear From Her, the conversation centers on a striking reality: women in healthcare often face a ...
GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas.
Regeneron has announced a strategic research collaboration with Parabilis Medicines to discover and develop multiple ...
AstronauTx has ppointed Michelle Mellion (pictured) as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, ...
The US FDA has approved Taiho’s Inqovi plus venetoclax as a treatment for adults with newly diagnosed acute myeloid leukaemia (AML). The approval is for patients who are 75 years or older or who are ...
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) ...
Eli Lilly and UNICEF USA have announced a collaboration aiming to improve non-communicable disease (NCD) prevention and care ...
Zeno is strengthening its European healthcare capabilities with the appointment of Cendrine Seror as Head of Health, Europe.
T40 listing – 2025 edition Click on a header to sort the list by each ranking factor. Click on an agency name or logo to view their profile page where you can read what the agency has to say about ...
Boehringer Ingelheim and Immunitas Therapeutics have announced a global licensing agreement for a preclinical antibody programme being developed for chronic inflammatory and autoimmune diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results